Stevanato Group S.p.A (STVN) Asset Writedowns and Impairment (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Asset Writedowns and Impairment came in at -$151026.2 in Q1 2026, up 63.37% year-on-year from -$92442.4 in Q1 2025, and down 127.78% on a QoQ basis from $543610.6 in Q3 2025.
Stevanato Group S.p.A (STVN) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Asset Writedowns and Impairment data on file, last reported at -$151026.2 in Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment rose 63.37% year-over-year to -$151026.2 in Q1 2026; TTM through Mar 2026 was $103629.3, a 186.87% increase from a year earlier, with the FY2021 full-year figure at -$1.5 million, down 475.77% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at -$151026.2, down from $543610.6 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for STVN reached as high as $746939.7 in Q2 2022 and fell as low as -$412338.7 in Q1 2025.
- Historically, Asset Writedowns and Impairment has averaged $72880.2 across 5 years, with a median of -$59303.9 in 2024.
- Across the five-year window, Asset Writedowns and Impairment tumbled 492.82% in 2024 and jumped 1016.65% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at -$80661.9 in 2022, then slumped by 364.25% to -$374475.1 in 2023, then surged by 84.16% to -$59303.9 in 2024, then soared by 1016.65% to $543610.6 in 2025, then sank by 127.78% to -$151026.2 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were -$151026.2 in Q1 2026, $543610.6 in Q3 2025, and $123383.6 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -151,026.19 |
| Mar 31, 2026 | -151,026.19 |
| Sep 30, 2025 | 543,610.62 |
| Sep 30, 2025 | 543,610.62 |
| Jun 30, 2025 | 123,383.61 |
| Jun 30, 2025 | 123,383.61 |
| Mar 31, 2025 | -412,338.70 |
| Mar 31, 2025 | -412,338.70 |
| Sep 30, 2024 | -59,303.85 |
| Sep 30, 2024 | -59,303.85 |
| Jun 30, 2024 | 575,057.97 |
| Jun 30, 2024 | 575,057.97 |
| Mar 31, 2024 | -222,704.16 |
| Mar 31, 2024 | -222,704.16 |
| Sep 30, 2023 | -374,475.12 |
| Sep 30, 2023 | -374,475.12 |
| Jun 30, 2023 | 358,256.12 |
| Jun 30, 2023 | 358,256.12 |
| Mar 31, 2023 | -37,566.96 |
| Mar 31, 2023 | -37,566.96 |